[Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].
作者信息
Schölmerich J
机构信息
Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg.
出版信息
Internist (Berl). 1997 Jun;38(6):582-9. doi: 10.1007/s001080050070.
PMID:9265003
Abstract
摘要
相似文献
1
[Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].
Internist (Berl). 1997 Jun;38(6):582-9. doi: 10.1007/s001080050070.
2
[Changing treatment of inflammatory bowel diseases].
Duodecim. 1994;110(20):1945-54.
3
5-aminosalicylates in inflammatory bowel disease--the more the merrier?
Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1017-9. doi: 10.1097/00042737-199511000-00001.
4
Current medical therapy for inflammatory bowel disease.
South Med J. 1996 Jun;89(6):556-66. doi: 10.1097/00007611-199606000-00002.
5
[Ulcerative colitis. Acute episode].
Z Gastroenterol. 2004 Sep;42(9):994-8. doi: 10.1055/s-2004-813518.
6
[Therapy of chronic inflammatory bowel diseases].
Ther Umsch. 1997 Nov;54(11):649-53.
7
Medical treatment of inflammatory bowel disease.
J Assoc Physicians India. 1995 Sep;43(9):627-31.
8
[Inflammatory bowel diseases].
Dtsch Med Wochenschr. 2004 Sep 3;129 Suppl 2:S73-5. doi: 10.1055/s-2004-831377.
9
Inflammatory bowel disease.
N Engl J Med. 2002 Aug 8;347(6):417-29. doi: 10.1056/NEJMra020831.
10
[Conservative therapy of Crohn disease--reliable measures based on clinical studies].
Internist (Berl). 1991 Sep;32(9):518-23.
Zotero 插件